Lupin Announces Final FDA Approval of Cefdinir for Oral Suspension (PR Newswire via Yahoo! Finance)
Lupin Pharmaceuticals, Inc. announced that it has received final approval from the U.S. Food and Drug Administration for its Abbreviated New Drug Application for Cefdinir Powder for Oral Suspension, 125 mg/5 mL.

MDS pushing to resolve issues at Montreal lab after Q2 profit withers to $16M (Canadian Business)
TORONTO (CP) - Resolving issues at its Montreal laboratory is MDS Inc.'s "No. 1 priority" after reporting Thursday that problems at the facility continued to drag on profits and threatened to delay key regulatory approvals.

Medidur(TM) Diabetic Macular Edema Programme: Government Approvals for International Clinical Phase III Trials (Business Wire via Yahoo! Finance)
BOSTON & PERTH, Australia & ATLANTA----June 7, 2006--Global bio-nanotech company pSivida Limited and development partner Alimera Sciences Inc., today announced that regulatory agencies in the U.K., Canada and India have approved the commencement of Phase III clinical trials of the Medidur device for the treatment of diabetic macular edema .